Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016969 |
---|---|
Receipt number | R000018400 |
Scientific Title | The examination of effects of adding on Tofogliflozin or not to add for type 2 diabetes controlled insufficiently by long-acting insulin glargine once daily with DPP-4 inhibitor or GLP-1 analog liraglutide with oral anti-diabetic agents (multicenter study) |
Date of disclosure of the study information | 2015/03/30 |
Last modified on | 2018/08/31 18:16:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/03/30 16:32:16 | ||
2 | Update | 2015/04/21 17:12:44 | Organization Organization Category of Funding Organization |
|
3 | Update | 2015/04/21 17:17:30 | Organization Organization Category of Funding Organization |
|
4 | Update | 2015/11/06 10:34:26 | Acronym |
|
5 | Update | 2015/11/24 15:54:31 | Randomization unit Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key inclusion criteria Target sample size |
|
6 | Update | 2015/11/24 16:02:38 | Primary outcomes Primary outcomes |
|
7 | Update | 2015/11/24 16:03:37 | Acronym |
|
8 | Update | 2016/05/14 15:20:31 | Name of primary person or sponsor Organization |
|
9 | Update | 2016/05/14 15:22:24 | Recruitment status |
|
10 | Update | 2017/05/10 17:39:58 | Last follow-up date |
|
11 | Update | 2017/09/30 13:23:44 | Other related information |
|
12 | Update | 2018/04/02 08:14:31 | Other related information Other related information |
|
13 | Update | 2018/08/31 18:16:04 | Recruitment status |